Markets:

Overview

News

Currencies

International

Treasuries

Penumbra, Inc. Common Stock (NY:PEN)

306.46 -4.45 (-1.43%)

Streaming Delayed Price Updated: 10:18 AM EST, Jan 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Penumbra, Inc. Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Winners And Losers Of Q1: Penumbra (NYSE:PEN) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

June 18, 2025

Let’s dig into the relative performance of Penumbra (NYSE:PEN) and its peers as we unravel the now-completed Q1 medical devices & supplies - cardiology, neurology, vascular earnings season.

Via StockStory

Peering Into Penumbra's Recent Short Interest ↗

June 18, 2025

Via Benzinga

3 Small-Cap Stocks Skating on Thin Ice

June 06, 2025

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a...

Via StockStory

3 Healthcare Stocks Walking a Fine Line

May 20, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID...

Via StockStory

Topics Stocks

What's Driving the Market Sentiment Around Penumbra? ↗

May 07, 2025

Via Benzinga

Breaking Down Penumbra: 12 Analysts Share Their Views ↗

April 24, 2025

Via Benzinga

Earnings Scheduled For April 23, 2025 ↗

April 23, 2025

Via Benzinga

PENUMBRA INC (NYSE:PEN) – A Strong Growth Stock with Technical Breakout Potential ↗

May 15, 2025

PENUMBRA INC (NYSE:PEN) is a strong growth stock with a bullish technical setup, supported by solid revenue and earnings growth. The company's financial health and breakout potential make it an...

Via Chartmill

1 High-Flying Stock on Our Buy List and 2 to Avoid

May 13, 2025

Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices,...

Via StockStory

PEN Q1 Earnings Call: U.S. Thrombectomy Drives Outperformance as International Headwinds Persist

May 12, 2025

Medical device company Penumbra (NYSE:PEN) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 16.3% year on year to $324.1 million. The company expects the full year’s revenue to be...

Via StockStory

Topics World Trade

3 Mid-Cap Medical Stocks Outperforming the Market

May 06, 2025

Several mid-cap medical stocks, such as ADMA, PEN, and TMDX, are outperforming in 2025, showing resilience despite broader market weakness.

Via MarketBeat

Topics Economy

Examining the Future: Penumbra's Earnings Outlook ↗

April 22, 2025

Via Benzinga

3 Profitable Stocks in the Doghouse

May 01, 2025

Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.

Via StockStory

Bausch + Lomb (BLCO) Reports Q1: Everything You Need To Know Ahead Of Earnings

April 29, 2025

Eyecare company Bausch + Lomb (NYSE:BLCO) will be reporting earnings tomorrow before market open. Here’s what you need to know.

Via StockStory

Topics World Trade

GE HealthCare (GEHC) Reports Q1: Everything You Need To Know Ahead Of Earnings

April 29, 2025

Healthcare technology company GE HealthCare Technologies (NASDAQ:GEHC) will be reporting earnings tomorrow before market hours. Here’s what to expect.

Via StockStory

Topics Artificial Intelligence World Trade

Align Technology Earnings: What To Look For From ALGN

April 29, 2025

Dental technology company Align Technology (NASDAQ:ALGN) will be reporting results tomorrow after market close. Here’s what you need to know.

Via StockStory

Topics Economy World Trade

What To Expect From CONMED’s (CNMD) Q1 Earnings

April 29, 2025

Medical tech company CONMED (NYSE:CNMD) will be reporting earnings tomorrow after market close. Here’s what you need to know.

Via StockStory

Topics World Trade

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 24, 2025

Via Benzinga

Penumbra Among Well-Insulated Companies From Ongoing Tariff Dynamics, Says Analyst ↗

April 24, 2025

Penumbra Q1 earnings beat estimates with strong sales and thrombectomy growth; analysts raise targets as company reaffirms 2025 guidance.

Via Benzinga

Topics Earnings

Penumbra’s (NYSE:PEN) Q1 Sales Beat Estimates, Stock Soars

April 23, 2025

Medical device company Penumbra (NYSE:PEN) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 16.3% year on year to $324.1 million. The company expects the full year’s...

Via StockStory

Topics Earnings

What To Expect From Penumbra’s (PEN) Q1 Earnings

April 22, 2025

Medical device company Penumbra (NYSE:PEN) will be reporting results tomorrow after the bell. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence

Reflecting On Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks’ Q4 Earnings: Merit Medical Systems (NASDAQ:MMSI)

April 17, 2025

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Merit Medical Systems...

Via StockStory

Unpacking Q4 Earnings: Artivion (NYSE:AORT) In The Context Of Other Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks

April 15, 2025

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - cardiology, neurology, vascular industry, including Artivion (NYSE:AORT) and...

Via StockStory

Is Penumbra Gaining or Losing Market Support? ↗

April 10, 2025

Via Benzinga

3 Reasons PEN is Risky and 1 Stock to Buy Instead

April 09, 2025

In a sliding market, Penumbra has defied the odds, trading up to $255.82 per share. Its 29.5% gain since October 2024 has outpaced the S&P 500’s 13.6% drop. This was partly due to its solid quarterly...

Via StockStory

Topics Stocks Supply Chain

Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q4 Earnings: ICU Medical (NASDAQ:ICUI) Best of the Bunch

March 25, 2025

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the medical devices & supplies - cardiology, neurology, vascular stocks, including ICU Medical (NASDAQ:ICUI) and its peers.

Via StockStory

Peering Into Penumbra's Recent Short Interest ↗

March 20, 2025

Via Benzinga

What Analysts Are Saying About Penumbra Stock ↗

March 14, 2025

Via Benzinga

ResMed Among Top Stocks For Recent And Long-Term Profit Growth ↗

March 10, 2025

A Relative Strength Rating upgrade for ResMed shows improving technical performance. Will it continue?

Via Investor's Business Daily

3 Mid-Cap Stocks in Hot Water

February 28, 2025

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with...

Via StockStory

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.